Overview of clinical data for rivaroxaban
pdf
Clinical trials of rivaroxaban (Xarelto) and the meta-analysis of their results are available for the following clinical conditions:
Acute coronary syndrome
All ACS (including AMI)
(in overview of all anticoagulant)
pdf
rivaroxaban vs placebo :
ATLAS ACS-TIMI 46 ,2009
-
ATLAS ACS TIMI 51 (ongoing)
-
all type of patient
(in overview of all antithrombotics)
pdf
rivaroxaban vs placebo :
ATLAS ACS-TIMI 46 ,2009
-
ATLAS ACS TIMI 51 (ongoing)
-
all type of patients
(in overview of all direct factor Xa inhibitors)
pdf
rivaroxaban vs placebo :
ATLAS ACS-TIMI 46 ,2009
-
ATLAS ACS TIMI 51 (ongoing)
-
patients with a recent ACS
(in overview of all antithrombotics)
pdf
rivaroxaban vs placebo :
ATLAS ACS-TIMI 46 ,2009
-
ATLAS ACS TIMI 51 (ongoing)
-
Atrial fibrillation
all type of patients
(in overview of all direct factor Xa inhibitors)
pdf
rivaroxaban vs warfarin standard dose :
ROCKET-AF ,2010
-
ROCKET J (ongoing)
-
all type of patients
(in overview of all new anticoagulants)
pdf
rivaroxaban vs warfarin standard dose :
ROCKET-AF ,2010
-
ROCKET J (ongoing)
-
primary prevention of thromboembolic events
(in overview of all antithrombotics)
pdf
rivaroxaban vs warfarin standard dose :
ROCKET J (ongoing)
-
ROCKET-AF ,2010
-
DVT prophylaxis
elective major knee surgery
(in overview of all new anticoagulants)
pdf
rivaroxaban vs enoxaparin (europe regimen) :
RECORD 3 ,2008
-
rivaroxaban vs enoxaparin (US regimen) :
ODIXa-KNEE ,2005
-
RECORD 4 ,2009
-
all type of patients
(in overview of all direct factor Xa inhibitors)
pdf
rivaroxaban vs enoxaparin :
RECORD 1 ,2008
-
rivaroxaban vs enoxaparin (europe regimen) :
RECORD 3 ,2008
-
rivaroxaban vs enoxaparin (short duration) :
ODIXa-HIP 10mg ,2006
-
rivaroxaban vs enoxaparin (US regimen) :
ODIXa-KNEE ,2005
-
RECORD 4 ,2009
-
rivaroxaban (long duration) vs enoxaparin (short duration) :
RECORD 2 ,2008
-
all type of patients
(in overview of all new anticoagulants)
pdf
rivaroxaban vs enoxaparin :
RECORD 1 ,2008
-
rivaroxaban vs enoxaparin (europe regimen) :
RECORD 3 ,2008
-
rivaroxaban vs enoxaparin (short duration) :
ODIXa-HIP 10mg ,2006
-
rivaroxaban vs enoxaparin (US regimen) :
ODIXa-KNEE ,2005
-
RECORD 4 ,2009
-
rivaroxaban (long duration) vs enoxaparin (short duration) :
RECORD 2 ,2008
-
elective hip replacement
(in overview of all antithrombotics)
pdf
rivaroxaban vs enoxaparin :
RECORD 1 ,2008
-
rivaroxaban vs enoxaparin (short duration) :
ODIXa-HIP 10mg ,2006
-
RECORD 2 ,2008
-
elective hip replacement
(in overview of all new anticoagulants)
pdf
rivaroxaban vs enoxaparin :
RECORD 1 ,2008
-
rivaroxaban vs enoxaparin (short duration) :
ODIXa-HIP 10mg ,2006
-
RECORD 2 ,2008
-
elective major knee surgery
(in overview of all antithrombotics)
pdf
rivaroxaban vs enoxaparin (europe regimen) :
RECORD 3 ,2008
-
rivaroxaban vs enoxaparin (US regimen) :
ODIXa-KNEE ,2005
-
RECORD 4 ,2009
-
medical patients
(in overview of all antithrombotics)
pdf
rivaroxaban vs enoxaparin :
MAGELLAN (ongoing)
-
orthopaedic surgery
(in overview of all new anticoagulants)
pdf
rivaroxaban vs enoxaparin :
RECORD 1 ,2008
-
rivaroxaban vs enoxaparin (europe regimen) :
RECORD 3 ,2008
-
rivaroxaban vs enoxaparin (short duration) :
ODIXa-HIP 10mg ,2006
-
rivaroxaban vs enoxaparin (US regimen) :
ODIXa-KNEE ,2005
-
RECORD 4 ,2009
-
rivaroxaban (long duration) vs enoxaparin (short duration) :
RECORD 2 ,2008
-
orthopedic surgery
(in overview of all anticoagulant)
pdf
rivaroxaban vs enoxaparin :
RECORD 1 ,2008
-
rivaroxaban vs enoxaparin (europe regimen) :
RECORD 3 ,2008
-
rivaroxaban vs enoxaparin (short duration) :
ODIXa-HIP 10mg ,2006
-
rivaroxaban vs enoxaparin (US regimen) :
ODIXa-KNEE ,2005
-
RECORD 4 ,2009
-
rivaroxaban (long duration) vs enoxaparin (short duration) :
RECORD 2 ,2008
-
orthopedic surgery
(in overview of all antithrombotics)
pdf
rivaroxaban vs enoxaparin :
RECORD 1 ,2008
-
rivaroxaban vs enoxaparin (europe regimen) :
RECORD 3 ,2008
-
rivaroxaban vs enoxaparin (short duration) :
ODIXa-HIP 10mg ,2006
-
rivaroxaban vs enoxaparin (US regimen) :
ODIXa-KNEE ,2005
-
RECORD 4 ,2009
-
rivaroxaban (long duration) vs enoxaparin (short duration) :
RECORD 2 ,2008
-
Pulmonary embolism
all type of patients
(in overview of all antithrombotics)
pdf
rivaroxaban vs placebo :
Einstein-PE Evaluation (ongoing)
-
Venous thrombosis
secondary prevention of VTE
(in overview of all antithrombotics)
pdf
extended rivaroxaban vs placebo :
EINSTEIN-extension ,2009
-
all type of patients
(in overview of all antithrombotics)
pdf
extended rivaroxaban vs placebo :
EINSTEIN-extension ,2009
-
rivaroxaban vs LMWH/VKA :
Einstein-DVT Dose-Ranging Study ,2008
-
Einstein-DVT Evaluation ,2010
-
rivaroxaban vs placebo :
Einstein-PE Evaluation (ongoing)
-
all type of patients
(in overview of all direct factor Xa inhibitors)
pdf
extended rivaroxaban vs placebo :
EINSTEIN-extension ,2009
-
rivaroxaban vs LMWH/VKA :
Einstein-DVT Dose-Ranging Study ,2008
-
Einstein-DVT Evaluation ,2010
-
rivaroxaban vs placebo :
Einstein-PE Evaluation (ongoing)
-
Entry terms: xarelto, rivaroxaban, xarelto, 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide, BAY 59-7939
See also relatic topics:
Search rivaroxaban clinical trials in
Pubmed
Search rivaroxaban clinical trials in
ClinicalTrials.gov
Search rivaroxaban clinical trials in
Wikipedia
Search rivaroxaban in
drugs.com
browse_trt3
|